BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18757407)

  • 1. A stochastic model for cancer stem cell origin in metastatic colon cancer.
    Odoux C; Fohrer H; Hoppo T; Guzik L; Stolz DB; Lewis DW; Gollin SM; Gamblin TC; Geller DA; Lagasse E
    Cancer Res; 2008 Sep; 68(17):6932-41. PubMed ID: 18757407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
    Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
    Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
    Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
    Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis.
    Husain K; Coppola D; Yang CS; Malafa MP
    Sci Rep; 2021 Jan; 11(1):2185. PubMed ID: 33500430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells as therapeutic targets of pancreatic cancer.
    Razi E; Radak M; Mahjoubin-Tehran M; Talebi S; Shafiee A; Hajighadimi S; Moradizarmehri S; Sharifi H; Mousavi N; Sarvizadeh M; Nejati M; Taghizadeh M; Ghasemi F
    Fundam Clin Pharmacol; 2020 Apr; 34(2):202-212. PubMed ID: 31709581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.
    Fidler IJ
    Cancer Res; 1990 Oct; 50(19):6130-8. PubMed ID: 1698118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
    Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
    Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro derivation and characterization of a colorectal cancer stem cell subpopulation].
    Davydov-Sinitsyn AP; Bazhenova OV; Liskovykh MA; Chechik LL; Ponomartsev CV; Tomilin AN; Tolkunova EN
    Tsitologiia; 2013; 55(5):318-23. PubMed ID: 24592739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of cancer stem cells.
    Lobo NA; Shimono Y; Qian D; Clarke MF
    Annu Rev Cell Dev Biol; 2007; 23():675-99. PubMed ID: 17645413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer.
    Qin Y; Shembrey C; Smith J; Paquet-Fifield S; Behrenbruch C; Beyit LM; Thomson BNJ; Heriot AG; Cao Y; Hollande F
    Cancer Lett; 2020 Apr; 476():161-169. PubMed ID: 32105676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
    Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
    Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
    Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
    Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.
    Cheung AH; Iyer DN; Lam CS; Ng L; Wong SKM; Lee HS; Wan T; Man J; Chow AKM; Poon RT; Pang R; Law WL
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
    Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of Krüppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer.
    Takagi Y; Sakai N; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Suzuki D; Kagawa S; Mishima T; Nakadai E; Miyauchi H; Matsubara H; Ohtsuka M
    Cancer Sci; 2020 Jun; 111(6):2078-2092. PubMed ID: 32279400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
    Sarkhosh-Inanlou R; Imani M; Sam MR
    Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition.
    Ishida R; Koyanagi-Aoi M; Oshima N; Kakeji Y; Aoi T
    Mol Cancer Res; 2017 Oct; 15(10):1455-1466. PubMed ID: 28710230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.